S. Faes

Discipline

Sociologie (1)

Type de document

Articles (13) Recensions (5)

Co-auteur

Date

Source

Mot-clé

Human beings (10) cancer (8) Cancer (8) Cancer (8) Treatment (7) Inhibitors (7) thérapie (6) Therapeutics (6) Inhibition (5) Animals (5) effet (4) Tumors (4) Protein kinases (4) Patients (4) Cells (4) Cancer cells (4) Cancer--Treatment (4) Use (4) Tumors (4) Patients (4) résistance (4) biologie (3) spectacle (3) ligne (3) taux (3) Neovascularization (3) Relevance (3) Mice (3) Experience (3) Example (3)

Documents écrit par S. Faes (13) | parle de S. Faes (0)

Dépistage du cancer anal. Expérience d’une décennie de consultation spécialisée [Anal cancer screening. A decade's experience of a consultation in a tertiary centre]
I. Espirito Santo et al. (14 juin 2023)
Rate of stoma formation following damage-control surgery for severe intra-abdominal sepsis: a single-centre consecutive case series.
S. Faes et al. (9 nov. 2021)
Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience.
P. Germani et al.
Elective Surgery for Diverticulitis in Swiss Hospitals.
S. Faes et al. (2021)
Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growth.
S. Faes et al. (4 juin 2019)
Colonic conduit prolapse after transanal total mesorectal excision (taTME).
A. Balaphas et al.
Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy.
S. Faes et al. (1 nov. 2017)
Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer.
E. Uldry et al. (30 juin 2017)
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity.
S. Faes et al. (2017)
Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies.
S. Faes et al. (27 déc. 2016)
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors.
S. Faes et al. (5 déc. 2016)
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
S. Faes et al. (14 juin 2016)
PI3K and AKT: Unfaithful Partners in Cancer.
S. Faes et al. (2015)